Autoimmune adrenal insufficiency: Recognition and management

BioDrugs

Volumn 13, Issue 2, 2000, Pages 107-114

  Winqvist, Ola ^a   Rorsman, Fredrik ^a   Kämpe, Olle ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID; POTASSIUM ION; SODIUM ION; STEROID 21 MONOOXYGENASE;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; ANOREXIA; ARTICLE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; ELECTROLYTE DISTURBANCE; FATIGUE; HUMAN; HYPERPIGMENTATION; HYPOTENSION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; STEROIDOGENESIS; WEIGHT REDUCTION;

EID: 0034064166     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200013020-00004     Document Type: Article

References (27)

1. 1. Mosser J, Douar A-M, Sarde C-O, et al. Punitive x-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993; 361: 726-30
2. 2. Miller WL. Molecular biology of steroid hormone synthesis. Endocr Rev 1988; 9: 295-318
3. 3. Addison T. On the constitutional and local effects of disease of the suprarenal capsules. In: Highley D, editor. London: 1855
4. 4. Nomura K, Demura H, Saruta T. Addison's disease in Japan: characteristics and changes revealed in a nationwide survey. Intern Med 1994; 33: 602-6
5. 5. Ofuji N, Yasuhara T, Murakami M, et al. A case of idiopathic Addison's disease with chronic thyroiditis and ovarian dysfunction. Jap J Med 1977; 16: 124-9
6. 6. Laureti S, Vecchi L, Santeusanio F, et al. Is the prevalence of Addison's disease underestimated. J Clin Endocrinol Metab 1999; 84: 1762
7. 7. Maclaren NK, Riley WJ. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with autoimmune polyglandular syndrome. J Clin Endocrinol Metab 1986; 62: 455-9
8. 8. John ME, John MC, Boggaram V, et al. Transcriptional regulation of steroid hydroxylase genes by corticotropin. Proc Natl Acad Sci USA 1986; 83: 4715-9
9. 9. Streeten DHP. Editorial: shortcomings in the low-dose (Iμg) ACTH test for the diagnosis of ACTH deficiency states. J Clin Endocrinol Metab 1999; 84: 835-7
10. 10. Clark PM, Neylon I, Raggatt PR, et al. Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol 1998; 49: 287-92
11. 11. Winqvist O, Karlsson FA, Kämpe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992; 339: 1559-62
12. 12. Bednarek J, Furmaniak J, Wedlock N, et al. Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS Lett 1992; 309: 51-5
13. 13. Uibo R, AAvik E, Peterson P, et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17 and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab 1994; 78: 323-8
14. 14. Song Y-H, Connor EL, Muir A, et al. Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease. J Clin Endocrin Metab 1994; 78: 1108-12
15. 15. Falorni A, Nikoshkov A, Laureti S, et al. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab 1995; 80: 2752-5
16. 16. Laureli S, Bellis AD, Muccitelli V, et al. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab 1998; 83: 3507-11
17. 17. Peterson P, Salmi H, Hyoty H, et al. Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood diabetes in Finland (DiMe) study group. Clin Immunol Immunopathol 1997; 82: 37-42
18. 18. Yu L, Brewer K, Gates S, et al. DRBI*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab 1999; 84: 328-35
19. 19. Boehm CD, Cutting G, Lachtermacher MB, et al. Accurate DNA-hased diagnostic and carrier testing for x-linked adrenoleukodystrophy. Mol Genet Metab 1999; 66: 128-36
20. 20. Orth DN, Kovacs WJ, Debold CR. The adrenal cortex. In: Wilson JD, Foster DW, editors. Williams textbook of endocrinology. 8th ed. Philadelphia: WB Saunders Company, 1992: 489-619
21. 21. Salem M, Tainish RE, Bromberg J, et al. Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg 1994; 219: 416-25
22. 22. Howlett T. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol 1997; 46: 263-8
23. 23. Peacey SR GC, Robinson AM, Price A, et al. Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol 1997; 46: 255-61
24. 24. Oelkers W, Diederich S, Bähr V. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) lest and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab 1992; 75: 259-64
25. 25. Peacey SR, Guo CY, Eastell R, et al. Optimization of glucocorticoid replacement therapy: the long-term effect on bone mineral density. Clin Endocrinol 1999; 50: 815-9
26. 26. Winqvist O, Gebre-Mehdin G, Gustafsson J, et al. Identification of the main adrenal autoantigens in patients with adrenal insufficiency and associated ovarian failure. J Clin Endocrinol Metab 1995; 80: 1717-23
27. 27. Arlt W, Callies F, Vlijmen JCv, et al. Dehydroepiandosterone replacement in women with adrenal insufficiency. N Engl J Med 1999; 341: 1013-20